ARTV
Artiva Biotherapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$11.19
+0.58%19
Insider buys (3m)
2
Insider sells (3m)
$17.6M
Net value (3m)
+63.0%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 31, 2026 | Banerjee Subhashis · officer: Chief Medical Officer | Sale | 8,222 | $12 |
| Aug 31, 2026 | Banerjee Subhashis · officer: Chief Medical Officer | M-Exempt | 5,306 | $1.92 |
| Aug 19, 2026 | Banerjee Subhashis · officer: Chief Medical Officer | M-Exempt | 429 | $1.92 |
| Aug 19, 2026 | Banerjee Subhashis · officer: Chief Medical Officer | Sale | 429 | $12 |
| Jul 31, 2026 | RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: | Purchase | 24,944 | $9.93 |
| Jul 31, 2026 | RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: | Purchase | 20,824 | $9.99 |
| Jul 28, 2026 | RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: | Purchase | 41,319 | $9.99 |
| Jul 23, 2026 | RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: | Purchase | 120,582 | $9.55 |
| Jul 23, 2026 | RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: | Purchase | 59,880 | $9.96 |
| Jul 23, 2026 | RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: | Purchase | 6,522 | $8.94 |
| Jul 23, 2026 | RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: | Purchase | 84,124 | $9.93 |
| Jul 20, 2026 | RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: | Purchase | 7,882 | $8.95 |
| Jul 20, 2026 | RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: | Purchase | 152,472 | $8.93 |
| Jul 14, 2026 | RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: | Purchase | 15,102 | $8.97 |
| Jul 14, 2026 | RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: | Purchase | 6,552 | $8.94 |
| Jun 29, 2026 | RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: | Purchase | 1,876 | $8.98 |
| Jun 29, 2026 | RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: | Purchase | 31,000 | $8.88 |
| Jun 16, 2026 | RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: | Purchase | 391,019 | $8.57 |
| Jun 16, 2026 | RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: | Purchase | 124,893 | $8.89 |
| Jun 16, 2026 | RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: | Purchase | 15,414 | $8.99 |
| Jun 11, 2026 | RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: | Purchase | 548,580 | $7.91 |
| Jun 11, 2026 | RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: | Purchase | 103 | $7.00 |
| Jun 11, 2026 | RA CAPITAL MANAGEMENT, L.P. · director, 10 percent owner: | Purchase | 479,039 | $6.91 |
| May 28, 2026 | GC Corp. · 10 percent owner | Purchase | 347,222 | $12 |
| May 28, 2026 | GC Corp. · 10 percent owner | Purchase | 1,085,069 | $12 |
| May 19, 2026 | Miralles Gines Diego · officer: President & Head of R&D | A-Award | 77,500 | $0.00 |
| May 19, 2026 | Aslan Fred · director, officer: Chief Executive Officer | Sale | 27,116 | $9.01 |
| May 19, 2026 | Banerjee Subhashis · officer: Chief Medical Officer | Sale | 7,037 | $9.01 |
| May 19, 2026 | Bush Jennifer · officer: COO, CLO, Compliance Officer | Sale | 8,790 | $9.01 |
| May 19, 2026 | Horan Christopher · officer: Chief Tech Operations Officer | Sale | 7,002 | $9.01 |
Institutional positioning
13F filings over the trailing two quarters
New 12Increased 4Reduced 13Sold out 39
| Filer | Action | Shares | Filed |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | Unchanged | 9,853,302 | May 15, 2026 |
| 5AM VENTURE MANAGEMENT, LLC | Unchanged | 2,353,304 | May 15, 2026 |
| VR ADVISER, LLC | Unchanged | 1,609,569 | May 15, 2026 |
| CITADEL ADVISORS LLC | Increased | 609,376 | Sep 2, 2026 |
| VENBIO PARTNERS LLC | Reduced | 531,337 | May 15, 2026 |
| FRANKLIN RESOURCES INC | Unchanged | 520,327 | May 13, 2026 |
| REVELATION CAPITAL MANAGEMENT, LLC | Unchanged | 299,311 | May 15, 2026 |
| BLACKROCK, INC. | Increased | 213,388 | May 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 207,686 | May 15, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | Unchanged | 194,108 | May 15, 2026 |
| PROPEL BIO MANAGEMENT, LLC | New Position | 146,369 | May 14, 2026 |
| MILLENNIUM MANAGEMENT LLC | Reduced | 123,270 | May 15, 2026 |
| TWO SIGMA INVESTMENTS, LP | Reduced | 115,041 | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 101,695 | May 15, 2026 |
| ALYESKA INVESTMENT GROUP, L.P. | Unchanged | 100,000 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 31, 2026